Training for Academic Hematology

学术血液学培训

• 批准号: 7587791
• 负责人: VICTOR JACK MARDER
• 金额: $ 5.63万
• 依托单位: UNIVERSITY OF CALIFORNIA LOS ANGELES
• 依托单位国家: 美国
• 财政年份: 2002
• 资助国家: 美国
• 起止时间: 2002-07-01 至 2012-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7587791
• 关键词: Academic Training; Hematology; Academic Training; Hematology

This application is for competitive renewal of a PHS Institutional National Service Award at the David Geffen School of Medicine at UCLA to prepare fellows for an academic career in Hematology. This award was nitiated in July, 2002, and supports 4 fellowship slots in years 2 and 3 of Hematology/Medical Oncology training. Of 11 fellows who have entered the program, 4 are currently in training and 7 have completed their fellowship, of which 4 are on the full-time faculty at UCLA, two are in clinical trial development with industry, and one has entered clinical practice. The faculty consists of 31 academic scientists and physicians, grouped into four areas of mutual research interest, Hematopoiesis and Stem Cell Biology (Kenneth Dorshkind, PhD, Director), Leukemia (Gary Schiller, MD, Director), Lymphocyte Biology and Lymphoma (Alan Lichtenstein, MD, Director) and Hemostasis, Thrombosis and Vascular Biology (Victor Marder, MD, Director). All the faculty have extramural research grant support, including 24 (77%) with NIHgrants. Interaction with other training programs in complementary disciplines emphasizes our goal of interactive basic and translational research careers. A research retreat is; held each spring, during which time each mentor presents an overview of the laboratories' research interest, followed by a report of the respective fellows' progress. Formal review of the mentor's effectiveness and the fellow's progress and goals are prepared by the Steering Committee, made up of the four Focus Directors. A core curriculum is offered to all fellows, including a "Clinical Research Course", which covers subjects on research design and analysis, ethics, regulatory,issues, grant preparation and responsible conduct of research. Fellows are encouraged to obtain an advanced degree as part of the STAR program, with formal course work in appropriate departments for one or two additional years. Of the 7 fellows who have completed their program during the interval 2002 - present, 2 have obtained the Master's degree and 1 has received a PhD degree. The training of hematologists with expertise in basic, clinical and translational research is an important priority for the David Geffen School of Medicine at UCLA and this application seeks support for the pivotal period between clinical training and an eventual career in academic hematology.

该申请是为了在David Geffen举行的PHS机构国家服务奖的竞争性更新 加州大学洛杉矶分校的医学学院为血液学学术生涯做好准备。这个奖项是 在2002年7月进行，并在血液学/医学肿瘤学的第2年和第3年中支持4个奖学金老虎机 训练。在参加该计划的11名研究员中，有4名正在接受培训，其中7个已经完成 奖学金，其中有4个是加州大学洛杉矶分校的全职教师，有两个正在与行业进行临床试验开发， 一个人进入了临床实践。该教师由31位学术科学家和医生组成 分为相互研究的四个领域，造血和干细胞生物学（肯尼斯 Dorshkind博士，导演），白血病（医学博士Gary Schiller，导演），淋巴细胞生物学和淋巴瘤 （医学博士Alan Lichtenstein，总监）和止血，血栓形成和血管生物学（Victor Marder，医学博士， 导演）。所有教师都有校外研究赠款的支持，其中包括24名（77％）的Nihgrants。 与互补学科中其他培训计划的互动强调了我们的互动目标 基本和转化研究职业。研究务虚会；每年春季举行，在此期间 导师概述了实验室的研究兴趣，然后是各自的报告 研究员的进步。对导师的有效性以及同伴的进步和目标的正式审查是 由指导委员会准备，由四个重点主管组成。向所有人提供核心课程 研究员，包括“临床研究课程”，涵盖研究设计和分析的主题， 道德，监管，问题，授予准备和负责任的研究行为。鼓励研究员 获得高级学位作为《星际计划》的一部分，并在适当的情况下进行正式课程工作 部门另外一两年。在完成计划期间完成计划的7名研究员中 Interval 2002-现在，有2个获得了硕士学位，其中1学位获得了博士学位。培训 具有基础，临床和转化研究专业知识的血液学家的重要性是 加州大学洛杉矶分校的David Geffen医学院，该应用程序寻求支持关键时期 临床培训和学术血液学的最终职业。